A pre-TCR-CD3 signal is required for the efficient maturation of CD4 -CD8 -thymocytes to the CD4 ⍣ CD8 ⍣ stage. This study addressed whether a similar signal is required for maturation of intestinal intraepithelial lymphocytes (IEL) that may develop extrathymically. We have shown previously that IEL from mice deficient for CD3-associated ζ chains include an immature population of CD3 -CD8αα ⍣ cells expressing cytoplasmic TCR β chains but lacking detectable surface TCRαβ, CD16 and B220. Here we stimulated the appearance of such IEL in ε ⍣/-ζ -/-mice by expression of an activated Lck transgene or in vivo treatment with anti-CD3ε. Anti-CD3ε treatment of RAG-deficient animals also yielded CD16 -B220 -IEL. In contrast, expression of a TCRβ transgene in rag-1 -/-mice did not stimulate the appearance of CD3 -CD8αα ⍣ CD16 -B220 -cells. Taken together these data indicate that although anti-CD3ε treatment and Lck F505 assist in catalyzing a CD16 ⍣ B220 ⍣ → CD16 -B220 -transition, these manipulations are not equivalent to a pre-TCR signal in IEL lymphocytes.
Introduction
Intraepithelial lymphocytes (IEL) of the small intestine include both TCRαβ-and TCRγδ-bearing T cells. A portion of these cells expresses an unusual form of the CD8 co-receptor, a CD8α homodimer (1, 2) , which distinguishes these IEL from conventional CD8αβ-expressing T cells that mature within the thymus. TCRαβ ϩ and TCRγδ ϩ IEL expressing CD8αα exhibit several additional characteristics which have led to the view that these cells differ from thymically derived T cells and may mature within the intestine (3, 4) . Firstly, they are able to utilize the Fc receptor γ chain in place of the CD3-associated ζ chain for TCR signaling. Thus, both TCRαβ ϩ and TCRγδ ϩ CD8αα ϩ IEL develop in mice deficient for ζ, while no mature thymically derived CD4 ϩ or CD8αβ ϩ T cells expressing high TCRαβ levels are present in these animals (5) (6) (7) (8) . Secondly, these IEL are dependent on the IL-2 receptor β chain for their CD4 ϩ CD8 ϩ thymocytes into mature CD4 ϩ or CD8αβ ϩ T cells requires a TCR signal resulting from recognition of a self peptide-MHC ligand within the thymic cortex (23) .
In contrast to the signals associated with thymocyte development, little is known regarding the lymphopoiesis which may commence in the recently described cryptopatches within the lamina propria and give rise to TCRαβ ϩ intestinal IEL (24, 25) . Kinetic studies (26) , as well as analyses of IEL from RAG-deficient and SCID mice (2, 3) , animals lacking both Lck and Fyn (27) , and young wild-type mice (26, 28) , suggest that CD3 -CD8α -CD44 ϩ IEL and CD3 -CD8αα ϩ IEL may include precursors of TCRαβ ϩ and TCRγδ ϩ IEL. RAG and pre-Tα transcripts are detected in IEL from SCID and nude mice respectively (29) (30) (31) , and this also supports the scenario that immature IEL rearrange their TCR genes and express pre-TCR in the intestine. Our recent data indicating that cells among the CD3 -CD8αα ϩ IEL express pre-Tα transcripts and exhibit V-DJ β gene rearrangement further support the view that some of these cells are committed to the T cell lineage (31) .
To pursue the nature of the CD8αα ϩ IEL maturation process, we utilized mice expressing a constitutively active Lck transgene (32) , as well as mice deficient for components of the TCR-CD3 signaling pathway (5, 19, 33) , to characterize possible precursors of TCRαβ ϩ CD8αα ϩ IEL and to determine whether mimicking a pre-TCR signal would drive IEL development. We have reported recently the appearance of a unique maturational intermediate for TCRαβ ϩ CD8αα ϩ IEL in ζ-deficient mice, that expresses CD8α homodimers and cytoplasmic TCR β chains, but lacks detectable surface TCRαβ expression (31) . Here we show that expression of an active Lck transgene or in vivo anti-CD3ε treatment of ε ϩ/-ζ -/-mice triggers the appearance of such CD3 -CD8αα ϩ cytoplasmic TCRβ ϩ IEL. After these manipulations, as well as upon anti-CD3ε treatment of RAG-deficient animals, the intermediate population that appears lacks CD16 and B220 expression. In contrast, expression of a TCRβ transgene in rag-1 -/-mice does not result in the appearance of CD3 -CD8αα ϩ CD16 -B220 -IEL. Together these data indicate that in contrast to their effects on thymocyte development, expression of active Lck and anti-CD3ε treatment do not mimic a pre-TCR signal in intestinal IEL.
Methods

Mice
Mice deficient for CD3ε and ζ have been reported previously (5, 19) . ζ -/-animals were crossed with mice bearing a constitutively active mutant of Lck, Lck F505 (32) , and their progeny were backcrossed with ζ -/-animals to generate ζ -/-Lck F505 offspring. ζ -/-Lck F505 mice were then crossed to ε -/-animals and the F 1 progeny were intercrossed to generate ε ϩ/-ζ -/-Lck F505 mice. Progeny were screened for CD3ε and ζ disruption and for the Lck F505 transgene by PCR. lck -/-fyn -/-mice (21) Surface and cytoplasmic staining for flow cytometric analyses IEL were isolated and purified as described (27, 41) . IEL and thymocytes were surface stained as reported (27) . For cytoplasmic staining, surface stained cells were washed and fixed by incubation in 100 µl of 4% paraformaldehyde in PBS for 20 min in the dark. Following three washes, the cells were permeabilized in FACS buffer (balanced salt solution ϩ 2% FCS ϩ 0.08% sodium azide) ϩ 0.1% saponin and blocked for 5 min on ice with anti-FcγRII/III in saponin. Intracellular staining for TCRβ was performed by incubation on ice with anti-TCRβ-FITC, followed by three washes in 0.1% saponin in FACS buffer.
Flow cytometric analysis and sorting
Multi-parameter cytometric analysis was performed on a FACScan flow cytometer using Lysys II software (Becton Dickinson, San Jose, CA) and flow cytometric analyses were plotted using ReproMan software (Truefacts Software, Seattle WA). All histograms are plotted on a logarithmic scale.
In vivo anti-CD3ε treatment
Mice were injected i.p. with 200 or 300 µg of anti-CD3ε antibody [145-2C11 (42)] purchased from Pharmingen, or hamster Ig, and were sacrificed 6 days later.
Results
CD3 -CD8αα ϩ IEL expressing cytoplasmic TCR β chains are detected in ε ϩ/-ζ -/-mice expressing a constitutively active form of Lck
We have previously shown that TCRαβ ϩ CD8αα ϩ IEL development is ablated in mice deficient for both Lck and Fyn, and that IEL in these mice are enriched for CD3 -CD8α -CD44 ϩ CD16 ϩ and CD3 -CD8αα ϩ CD16 ϩ B220 ϩ putative IEL precursors (27) . Our data suggested that these src-family PTK control development of the TCRαβ ϩ IEL population in Fig. 1 . CD3 -CD8αα ϩ IEL express cytoplasmic TCR β chains in ε ϩ/-ζ -/-Lck F505 mice. Thymocytes and IEL were isolated from ε ϩ/-ζ -/-, ε ϩ/-ζ -/-Lck F505 , C57BL/6 (B6) and rag-1 -/-mice, and were stained for three-color flow cytometry. For the thymus, surface staining was performed using anti-CD4-PE, anti-CD8α-TC and anti-TCRβ-FITC. To stain cytoplasmic TCRβ, thymocytes were stained on the surface with anti-CD8α-TC and anti-TCRβ-PE, permeabilized in saponin, and stained intracellularly with anti-TCRβ-FITC. Purified IEL were surface stained with anti-CD8α-TC, anti-B220-PE or anti-TCRβ-PE, and anti-CD16/32-FITC. Intracellular IEL staining was performed using anti-TCRβ-FITC in saponin. IEL staining is shown after gating on lymphocytes by forward and side scatter, and for CD8α expression. Data are presented on a logarithmic scale. cTCRβ and sTCRβ represent cytoplasmic and surface TCRβ expression respectively. The percentage of CD8α ϩ cells falling within each rectilinear gate is shown. Results are representative of analyses performed in at least three separate experiments using 4-to 8-week-old mice. The data from six similar experiments are shown in Table 1. situ and, therefore, we posited that a constitutively active mutant of Lck might facilitate development of more mature cells in this IEL lineage. To test this hypothesis, we analyzed IEL from ε ϩ/-ζ -/-animals in the presence or absence of the Lck F505 transgene. Due to the lack of CD3-associated ζ chains, ε ϩ/-ζ -/-mice have no mature TCRαβ ϩ IEL expressing CD4 or CD8αβ heterodimers (5) (6) (7) 31) . However, the immature T lymphocytes in these mice do express low levels of the CD3 component ε and therefore can transmit CD3-mediated signals. Thus, these animals provide an ideal source of IEL in which to study the development of TCRαβ ϩ CD8αα ϩ cells that putatively mature within the small intestine.
The Lck F505 transgene, expressed under control of the lck proximal promoter, encodes a constitutively active mutant of Lck that is altered at the negative regulatory residue, Y505 (32) . In the thymus of RAG-deficient mice, overexpression of this Lck F505 transgene facilitates maturation of CD4 -CD8 -thymocytes to the CD4 ϩ CD8 ϩ stage and expansion of the pool of CD4 ϩ CD8 ϩ thymocytes to wild-type levels (43) . As shown in Fig. 1 , ε ϩ/-ζ -/-mice have only a small proportion of CD4 ϩ CD8 ϩ thymocytes and expression of the Lck F505 transgene on this background promotes the CD4 -CD8 -to CD4 ϩ CD8 ϩ transition.
Mature TCRαβ ϩ and TCRγδ ϩ IEL were absent in ε ϩ/-ζ -/-mice whether or not they expressed the Lck F505 transgene ( Fig. 1 and data not shown) . However, cytoplasmic staining revealed an increase in the representation of IEL expressing TCR β chains in the ε ϩ/-ζ -/-Lck F505 mice compared to their ε ϩ/-ζ -/-littermates ( Fig. 1 and Table 1 ), whereas the majority of CD8α ϩ IEL in ε ϩ/-ζ -/-and rag-1 -/-mice express CD16 and B220, a significant fraction of the CD8α ϩ cells in the ε ϩ/-ζ -/-Lck F505 mice lack expression of these markers ( Fig. 1 and Table 1 ). The CD8α ϩ IEL pool in the C57BL/6 mice includes both mature TCRαβ and TCRγδ cells, some of which express these two markers, and this results in the continuum for both CD16 and B220 expression ( Fig. 1 and data not shown) . In these wild-type mice the IEL precursors represent an insignificant proportion of the total CD8α ϩ IEL.
Since CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL are present in ε ϩ/-ζ -/-Lck F505 mice but not in their ε ϩ/-ζ -/-littermates, expression of a constitutively active mutant of Lck appears to drive the development of cells in the TCRαβ ϩ CD8αα ϩ IEL lineage.
CD3 signaling drives maturation of IEL in rag-1 -/-and ε ϩ/-ζ -/-mice but not in lck -/-fyn -/-animals It has been reported previously that thymocyte maturation in RAG-or TCRβ-deficient mice can be driven from the CD4 -CD8 -to the CD4 ϩ CD8 ϩ stage by in vivo treatment with anti-CD3ε (17, (44) (45) (46) . This antibody treatment has been suggested to mimic the pre-TCR signal in CD4 -CD8 -thymocytes. We postulated that if a signal from the pre-TCR, mediated by CD3 components and the src-family PTK Lck or Fyn, is required for the appearance of CD8αα ϩ IEL expressing detectable levels of cytoplasmic TCR β chains, it might be possible to mimic such a signal using anti-CD3ε treatment in vivo.
As expected, anti-CD3ε treatment of rag-1 -/-and ε ϩ/-ζ -/-mice resulted in the appearance of significant numbers of CD4 ϩ CD8 ϩ thymocytes (Fig. 2) . The thymocytes of RAGdeficient mice could not rearrange their TCR genes and therefore their CD4 ϩ CD8 ϩ cells lacked expression of TCRβ protein (Fig. 2) . In contrast, in anti-CD3ε-treated ε ϩ/-ζ -/-mice, many of the CD4 ϩ CD8 ϩ thymocytes expressed cytoplasmic TCRβ although they lacked surface TCRαβ (Fig. 2 and data  not shown) .
In the control rag-1 -/-mice treated with hamster Ig the CD8α ϩ IEL expressed CD16 and B220 ( Fig. 2 and Table 2 ). However, 6 days after anti-CD3ε treatment, CD8α ϩ IEL lacking CD16 and B220 expression were detected in the rag-1 -/-mice ( Fig. 2 and Table 2 ). Moreover, the CD8α ϩ IEL in ε ϩ/-ζ -/-mice expressed CD16 and B220, but lacked surface TCR, and anti-CD3ε treatment of these mice also resulted in the appearance of CD3 -CD8αα ϩ CD16 -B220 -IEL, a fraction of which expressed cytoplasmic TCR β chains (Fig. 2 , Table 2 and data not shown).
It is noteworthy that these CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL and CD3 -CD8αα ϩ CD16 -B220 -found in anti-CD3ε treated ε ϩ/-ζ -/-and rag-1 -/-animals respectively were indistinguishable in size from those present in ε ϩ/-ζ -/-Lck F505 mice, and were intermediate between the larger CD3 -CD8αα ϩ CD16 ϩ B220 ϩ IEL and the smaller, mature CD3 ϩ cells (data not shown). All told, anti-CD3ε treatment of ε ϩ/-ζ -/-and rag-1 -/-mice appears to drive the development of cells in the TCRαβ ϩ CD8αα ϩ IEL lineage.
In marked contrast, CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL did not appear in anti-CD3ε treated lck -/-fyn -/-mice (Fig. 3) , although the disappearance of the TCRγδ ϩ cells in these animals clearly indicated that the anti-CD3ε reagent reached the IEL compartment (Fig. 3) , either causing downregulation of surface TCRγδ or elimination of TCRγδ ϩ IEL. This result is compatible with a role for Lck and Fyn acting downstream of CD3, and mediating a signal necessary for the appearance of the CD3 -CD8αα ϩ cytoplasmic TCRβ ϩ IEL population.
Rearranged TCRβ transgenes are expressed in CD3 -CD8αα ϩ CD16 ϩ B220 ϩ IEL in rag-1 -/-mice Previous analyses of thymic development in RAG-deficient mice expressing a rearranged TCRβ chain transgene demonstrated that thymocytes in these animals advance to the CD4 ϩ CD8 ϩ stage (20, 45, 47) and that Lck is involved in mediating a signal required for this transition (43, 46, 48, 49) . These results support the hypothesis that a signal generated via the pre-TCR is required for the CD4 -CD8 -to CD4 ϩ CD8 ϩ transition during thymopoiesis. One possible interpretation of our results outlined above is that a similar pre-TCR-generated signal is required for the development of CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL in situ. We therefore analyzed IEL from rag-1 -/-mice which bore either a V β 8 (34) or V β 3 (35) rearranged TCRβ transgene.
As previously reported, thymocyte development proceeds to the CD4 ϩ CD8 ϩ stage in rag-1 -/-ϩTCRβ animals (45,47) (Fig. 4) . Surprisingly, while intracellular staining of IEL from rag-1 -/-ϩTCRβ mice clearly shows expression of the transgene in CD3 -CD8αα ϩ IEL, these cells retain expression of CD16 and B220 (Fig. 4) . This was the case whether the V β 3 or V β 8 transgenes, which include different a Data from this experiment are also shown in Fig. 2. promoter elements, were introduced (Fig. 4 and data not shown). These results suggest that the expression of a rearranged TCRβ transgene in CD3 -CD8αα ϩ CD16 ϩ B220 ϩ IEL in rag-1 -/-animals is insufficient to drive the generation of CD3 -CD8αα ϩ CD16 -B220 -IEL from their putative IEL precursors.
Discussion
The maturation of thymocytes proceeds via a well-characterized pathway. In mice deficient for RAG, TCRβ, pre-Tα, CD3ε or both Lck and Fyn, thymocyte development is blocked at the CD4 -CD8 -CD44 -CD25 ϩ stage (19) (20) (21) 33, 50) . During thymopoiesis, the pre-TCR signal, necessary for the CD4 -CD8 -to CD4 ϩ CD8 ϩ transition and expansion of the CD4 ϩ CD8 ϩ thymocyte pool, can be mimicked by anti-CD3ε treatment (17, (44) (45) (46) or by overexpression of a constitutively active mutant of Lck (43) . To determine whether a parallel developmental scheme operates for the extrathymic maturation of IEL residing in the small intestine, these cells have been examined from mice deficient in various TCR signaling components. A compilation of published data and our results lead us to propose one possible scheme for the maturational pathway underlying the emergence of TCRαβ ϩ CD8αα ϩ IEL, which is shown in Fig. 5 . Briefly, analyses of IEL from RAG-deficient and SCID mice indicate a block in TCRαβ ϩ CD8αα ϩ IEL development (2,3). Moreover, our recent studies of mice deficient for both Lck and Fyn (27) , or lacking CD3ε (31), imply a similar perturbation in maturation of IEL of the TCRαβ ϩ lineage. IEL from all these mice include CD3 -CD8α -CD44 ϩ and CD3 -CD8αα ϩ CD16 ϩ B220 ϩ IEL, which may include precursors of both TCRαβ ϩ and TCRγδ ϩ CD8αα ϩ IEL (Figs 1  and 3) (27, 31, 51) . Evidence suggests that ζ-deficient IEL substitute the FcR γ chain for TCR signaling (5-7), and perhaps because γ includes only one immunoreceptor tyrosine-based activation motif (ITAM) while ζ has three, these ζ -/-IEL mature only inefficiently. We have reported that ζ -/-animals include CD3 -CD8αα ϩ cytoTCRβ ϩ IEL lacking CD16 and B220 expression (31), which could be intermediates in IEL development as suggested (52) . IEL from wild-type mice include negligible numbers of these cells, which might rapidly rearrange their TCRα genes and mature to express surface TCR.
Here we demonstrate that partial maturation of RAG-deficient IEL, as judged by the loss of CD16 and B220 expression, can be stimulated in vivo by anti-CD3ε antibodies ( Fig. 2 and Table 2 ). A similar finding has been reported recently by Terhorst et al. (52) . Moreover, if CD3ε is made limiting by gene dosage in mice also lacking ζ, the appearance of CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL can be stimulated by expression of active Lck ( Fig. 1 and Table 1 ) or by anti-CD3ε treatment ( Fig. 2 and Table 2 ). However, complete elimination of CD3ε results in the absence of this putative immature IEL population, and it cannot be rescued by the Lck F505 transgene (Page and Pullen, unpublished data).
Our results using the active Lck F505 transgene and anti-CD3ε antibody treatment suggest that CD4 ϩ CD8 ϩ thymocytes and CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL require similar signals for their generation; however, the data from analyses of RAG-deficient mice expressing two different TCRβ transgenes (Fig. 4) indicate that the developmental requirements for these two immature T cells can be distinguished. These studies demonstrate that the condition of TCR components and their associated signaling structures can influence the cell surface phenotype of CD3 -CD8α ϩ IEL, in a manner that suggests that CD16 ϩ B220 ϩ IEL down-regulate these markers and subsequently up-regulate levels of cytoplasmic TCRβ protein (Fig. 2) . Although anti-CD3ε and Lck F505 may assist in catalyzing a transition from CD16 ϩ B220 ϩ to CD16 -B220 -, this does not reflect a signaling process wholly analogous to that entrained by the pre-TCR since expression of TCRβ cannot, by itself, reconstitute the defect observed in RAG-deficient mice (Fig. 4) . It is unlikely that pre-TCR cannot be expressed in these IEL, since pre-Tα transcripts are detectable in these rag-1 -/-mice (31), and TCRβ is expressed in the cytoplasm of the 2B4β transgenic IEL and also on the surface, perhaps as ββ dimers, of the HY transgenic IEL.
In addition, it should be noted that Lck F505 promotes the appearance of cytoplasmic TCRβ ϩ cells in the IEL compartment, but antagonizes β chain gene rearrangement and hence expression in thymocytes ( Fig. 1) (53,54) .
Taken together, these data suggest that the CD3 -CD8αα ϩ CD16 -B220 -IEL expressing cytoplasmic TCR β chains may represent developmental intermediates of the TCRαβ lineage maturing within the intestinal epithelium. Cells of this phenotype are not found in the thymus or lymph nodes (data not shown). Our analyses of IEL from rag-1 -/-ϩ TCRβ mice (Fig. 4) and ZAP70 -/-mice (Page et al., unpublished observations) indicate that these animals lack CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL despite abundant populations of CD4 ϩ CD8 ϩ thymocytes. Hence these data suggest that CD3 -CD8αα ϩ cytoTCRβ ϩ CD16 -B220 -IEL are not derived from CD4 ϩ CD8 ϩ thymocytes which have turned off CD4 and CD8β expression. Moreover, our earlier study of the methylation state of the CD8β promoter among CD8αα ϩ IEL also suggests these cells do not arise from CD8β-expressing precursors (55) .
Overall, our data are consistent with the model presented in Fig. 5 for the extrathymic maturation sequence that underlies the emergence of TCRαβ ϩ CD8αα ϩ IEL in the small intestine. They indicate that the signals derived from TCR components, including the Lck PTK, participate in regulating the relative representation of the maturation intermediates. Furthermore, our results provide additional evidence that signaling during IEL maturation differs from that regulating thymocyte development. Although expression of a constitutively active Lck transgene, anti-CD3ε treatment and expression of a TCRβ transgene in RAG-deficient mice all apparently mimic a pre-TCR signal during thymopoiesis, these manipulations are not equivalent in driving TCRαβ ϩ CD8αα ϩ IEL development. 
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